Recent Finacing
Recent Raise
Allink Biotherapeutics develops differentiated antibody-drug conjugates (ADCs) and multi-specific antibodies to treat oncology and immunology indications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Allink Biotherapeutics.
